Accordingly, pharmacological inhibition of Cdk4 and Cdk6 prevented tumor development in mouse models of breast cancer, sustained by cyclin D1, and leukemia, sustained by cyclin D3 [13]. The gene discussed is CDK4; the disease is breast carcinoma.